UNICK FIX-A-FORM AND PRINTERS | GLENMARK LIFE SCIENCES | UNICK FIX-A-FORM AND PRINTERS/ GLENMARK LIFE SCIENCES |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 27.9 | 21.0 | 132.8% | View Chart |
P/BV | x | 1.1 | 4.6 | 24.7% | View Chart |
Dividend Yield | % | 0.0 | 2.6 | - |
UNICK FIX-A-FORM AND PRINTERS GLENMARK LIFE SCIENCES |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
UNICK FIX-A-FORM AND PRINTERS Mar-23 |
GLENMARK LIFE SCIENCES Mar-23 |
UNICK FIX-A-FORM AND PRINTERS/ GLENMARK LIFE SCIENCES |
5-Yr Chart Click to enlarge
|
||
High | Rs | 59 | 534 | 11.1% | |
Low | Rs | 32 | 369 | 8.5% | |
Sales per share (Unadj.) | Rs | 120.5 | 176.4 | 68.3% | |
Earnings per share (Unadj.) | Rs | 4.1 | 38.1 | 10.7% | |
Cash flow per share (Unadj.) | Rs | 11.2 | 41.5 | 27.0% | |
Dividends per share (Unadj.) | Rs | 0 | 21.00 | 0.0% | |
Avg Dividend yield | % | 0 | 4.7 | 0.0% | |
Book value per share (Unadj.) | Rs | 53.9 | 174.0 | 31.0% | |
Shares outstanding (eoy) | m | 5.49 | 122.53 | 4.5% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 0.4 | 2.6 | 14.7% | |
Avg P/E ratio | x | 11.1 | 11.8 | 93.5% | |
P/CF ratio (eoy) | x | 4.0 | 10.9 | 37.1% | |
Price / Book Value ratio | x | 0.8 | 2.6 | 32.3% | |
Dividend payout | % | 0 | 55.1 | 0.0% | |
Avg Mkt Cap | Rs m | 248 | 55,321 | 0.4% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 90 | 1,802 | 5.0% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 662 | 21,612 | 3.1% | |
Other income | Rs m | 5 | 290 | 1.8% | |
Total revenues | Rs m | 667 | 21,902 | 3.0% | |
Gross profit | Rs m | 88 | 6,423 | 1.4% | |
Depreciation | Rs m | 39 | 421 | 9.3% | |
Interest | Rs m | 24 | 5 | 435.5% | |
Profit before tax | Rs m | 30 | 6,286 | 0.5% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 7 | 1,616 | 0.5% | |
Profit after tax | Rs m | 22 | 4,670 | 0.5% | |
Gross profit margin | % | 13.3 | 29.7 | 44.6% | |
Effective tax rate | % | 25.0 | 25.7 | 97.2% | |
Net profit margin | % | 3.4 | 21.6 | 15.7% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 301 | 23,687 | 1.3% | |
Current liabilities | Rs m | 287 | 10,228 | 2.8% | |
Net working cap to sales | % | 2.1 | 62.3 | 3.4% | |
Current ratio | x | 1.0 | 2.3 | 45.3% | |
Inventory Days | Days | 4 | 2 | 239.6% | |
Debtors Days | Days | 72,349,839 | 136 | 53,100,192.7% | |
Net fixed assets | Rs m | 402 | 8,518 | 4.7% | |
Share capital | Rs m | 55 | 245 | 22.4% | |
"Free" reserves | Rs m | 241 | 21,070 | 1.1% | |
Net worth | Rs m | 296 | 21,315 | 1.4% | |
Long term debt | Rs m | 89 | 0 | - | |
Total assets | Rs m | 705 | 32,205 | 2.2% | |
Interest coverage | x | 2.3 | 1,150.2 | 0.2% | |
Debt to equity ratio | x | 0.3 | 0 | - | |
Sales to assets ratio | x | 0.9 | 0.7 | 139.8% | |
Return on assets | % | 6.6 | 14.5 | 45.1% | |
Return on equity | % | 7.6 | 21.9 | 34.6% | |
Return on capital | % | 14.0 | 29.5 | 47.3% | |
Exports to sales | % | 0 | 0 | - | |
Imports to sales | % | 0 | 0 | - | |
Exports (fob) | Rs m | NA | NA | - | |
Imports (cif) | Rs m | NA | NA | - | |
Fx inflow | Rs m | 0 | 9,691 | 0.0% | |
Fx outflow | Rs m | 0 | 5,001 | 0.0% | |
Net fx | Rs m | 0 | 4,689 | 0.0% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 44 | 3,134 | 1.4% | |
From Investments | Rs m | -27 | -1,541 | 1.8% | |
From Financial Activity | Rs m | -16 | -3,876 | 0.4% | |
Net Cashflow | Rs m | 0 | -2,283 | -0.0% |
Indian Promoters | % | 71.6 | 82.9 | 86.4% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.5 | 6.4 | 7.0% | |
FIIs | % | 0.0 | 5.0 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 28.4 | 17.2 | 165.8% | |
Shareholders | 1,622 | 156,183 | 1.0% | ||
Pledged promoter(s) holding | % | 0.0 | 9.5 | - |
Compare UNICK FIX-A-FORM AND PRINTERS With: DIVIS LABORATORIES SUN PHARMA CIPLA DR. REDDYS LAB ZYDUS LIFESCIENCES
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | UNICK FIX-A-FORM AND PRINTERS | GLENMARK LIFE SCIENCES | S&P BSE TECK |
---|---|---|---|
1-Day | 0.00% | -0.62% | 0.12% |
1-Month | 21.23% | 3.07% | -1.24% |
1-Year | 60.49% | 56.18% | 26.38% |
3-Year CAGR | 30.30% | 2.63% | 10.30% |
5-Year CAGR | 21.81% | 1.57% | 14.89% |
* Compound Annual Growth Rate
Here are more details on the UNICK FIX-A-FORM AND PRINTERS share price and the GLENMARK LIFE SCIENCES share price.
Moving on to shareholding structures...
The promoters of UNICK FIX-A-FORM AND PRINTERS hold a 71.6% stake in the company. In case of GLENMARK LIFE SCIENCES the stake stands at 82.9%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of UNICK FIX-A-FORM AND PRINTERS and the shareholding pattern of GLENMARK LIFE SCIENCES.
Finally, a word on dividends...
In the most recent financial year, UNICK FIX-A-FORM AND PRINTERS paid a dividend of Rs 0.0 per share. This amounted to a Dividend Payout ratio of 0.0%.
GLENMARK LIFE SCIENCES paid Rs 21.0, and its dividend payout ratio stood at 55.1%.
You may visit here to review the dividend history of UNICK FIX-A-FORM AND PRINTERS, and the dividend history of GLENMARK LIFE SCIENCES.
For a sector overview, read our media sector report.
Asian stocks got off to a positive start on Monday ahead of the Federal Reserve's policy meeting later in the week.